MedFusion-gP-AKI: development and multicenter validation of a machine learning fusion model for early prediction of KDIGO stage 3 acute kidney injury in critically ill traumatic cervicothoracic spinal cord injury patients

MedFusion-gP-AKI:开发和多中心验证一种机器学习融合模型,用于早期预测危重创伤性颈胸段脊髓损伤患者的KDIGO 3期急性肾损伤

阅读:3

Abstract

KDIGO stage-3 acute kidney injury (AKI), a life-threatening complication in critically ill patients with traumatic cervicothoracic spinal cord injury (TCTSCI), was associated with a 49.3% 60-day mortality and a median survival of 20 days in a combined MIMIC-IV/eICU analysis, underscoring its severe clinical consequences and the need for early identification and prediction. To address this need, MedFusion-GP-AKI was developed as a multimodal deep learning framework trained on the MIMIC-IV/eICU cohort and externally validated in 188 patients from four tertiary Chinese centers. Missing data were imputed with a GAN-based method, and key predictors were derived from the original dataset using NOTEARS, variational bottleneck, and adversarial analysis, yielding eleven variables led by lactate, mean arterial pressure, temperature, potassium, and TCTSCI level, with the dataset subsequently balanced using an SMOTified-GAN. Fifteen baseline models were benchmarked under uniform protocols, and the best-performing architectures were integrated into an ensemble that achieved AUCs of 0.938, 0.909, 0.969, 0.945, and 0.921 with APs of 0.841, 0.884, 0.992, 0.927, and 0.878 across pre- and post-SMOTE training, validation, and external cohorts, demonstrating reliable discrimination and calibration, stable clinical net benefit across thresholds, and balanced overall classification performance with strong generalizability across independent institutions. SHAP analysis confirmed that model attributions aligned with known clinical and physiological patterns, and a web-based calculator was developed for practical use. Overall, this study connects artificial intelligence, nephrology, and critical care by using multimodal deep learning and causal inference to predict severe AKI occurrence from early clinical data in critically ill TCTSCI patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。